Business
Ehave Advances MedReleaf Collaboration with Launch of Digital Patient Intake Portal
Ehave Advances MedReleaf Collaboration with Launch of Digital Patient Intake Portal.
About this update from Ehave Inc.
[{"type":"text","content":"\n\n\n\nEhave Advances MedReleaf Collaboration with Launch of Digital Patient Intake Portal\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nEhave Advances MedReleaf Collaboration with Launch of Digital Patient Intake Portal\nCanada NewsWire\nTORONTO, Nov. 1, 2017\n\n\n\nTORONTO, Nov. 1, 2017 /CNW/ -- Ehave, Inc. (OTCQB: EHVVF), a healthcare company dedicated to empowering the mental health community with next-generation digital solutions, today announced the launch of a robust digital patient intake system, in collaboration with MedReleaf Corp. (TSE: LEAF), Canada's premium medical cannabis licensed producer, to facilitate the objective clinical assessment and optimization of cannabis-based therapies for treating a variety of health conditions.\n\nEhave's technology will be integrating with MedReleaf's patient and physician dashboard that is used to establish baseline patient assessments and track patient-reported symptoms by incorporating a broad panel of clinically-validated surveys into a single digital portal.  \"The core of our business is focused on improving outcomes for our patients and using advanced data-driven technology to support and validate efficacy in cannabis-based medicine,\" says Neil Closner, CEO of MedReleaf.  This first tool will be integrated with future compliance and reporting offerings co-developed by Ehave and MedReleaf that will empower patients in their treatment plans, help both patients and healthcare practitioners to encourage treatment compliance, and verify treatment outcomes in a reliable and objective manner. \n\n\"We're pleased to advance our flagship collaboration with MedReleaf and launch this first product offering for the investigation of cannabis-based therapies,\" said Prateek Dwivedi, CEO of Ehave. \"Our core data management technology allows us to incorporate and centralize any number of validated or novel patient assessments and surveys into various formats such as our Ehave Connect clinician portal, customized Apps, engaging video games, and other digital platforms.  The true power of our technology is in...